Clinical Trial Update: Levofloxacin Prophylaxis to Prevent First Febrile Neutropenia in Pediatric ALL During Induction Phase [Phase 4]

View source ↗

Summary

This clinical trial update describes a Phase 4 study evaluating levofloxacin prophylaxis to prevent the first febrile neutropenia during induction in pediatric …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Neutropenic Fever

Drugs mentioned

• Levofloxacin (Levofloxacin)

Snippet

Sponsor: Gadjah Mada University | Conditions: Neutropenic Fever, Acute Lymphoblastic Leukemia | Phase 4 | Status: NOT_YET_RECRUITING